Genomed Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 48

Employees

  • Stock Symbol
  • GEN

Stock Symbol

  • Share Price
  • $6.95
  • (As of Friday Closing)

Genomed General Information

Description

Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.

Contact Information

Website
www.genomed.pl
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Ul. Ponczowa 12
  • Warsaw, 02-971
  • Poland
+48 22
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Diagnostic Equipment
Stock Exchange
WAR
Vertical(s)
Life Sciences
Corporate Office
  • Ul. Ponczowa 12
  • Warsaw, 02-971
  • Poland
+48 22

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomed Stock Performance

As of 06-Jun-2025, Genomed’s stock price is $6.95. Its current market cap is $9.2M with 1.32M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.95 $6.65 $6.06 - $7.65 $9.2M 1.32M 46.68 $0.37

Genomed Financials Summary

As of 31-Mar-2025, Genomed has a trailing 12-month revenue of $6.09M.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 7,611 7,701 9,325 9,550
Revenue 6,089 5,775 5,348 4,586
EBITDA 711 491 397 245
Net Income 492 277 220 76
Total Assets 3,241 3,014 3,037 2,366
Total Debt 0 0 2 5
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genomed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genomed‘s full profile, request access.

Request a free trial

Genomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomed Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genomed‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial

Genomed FAQs

  • When was Genomed founded?

    Genomed was founded in 2007.

  • Where is Genomed headquartered?

    Genomed is headquartered in Warsaw, Poland.

  • What is the size of Genomed?

    Genomed has 48 total employees.

  • What industry is Genomed in?

    Genomed’s primary industry is Biotechnology.

  • Is Genomed a private or public company?

    Genomed is a Public company.

  • What is Genomed’s stock symbol?

    The ticker symbol for Genomed is GEN.

  • What is the current stock price of Genomed?

    As of 06-Jun-2025 the stock price of Genomed is $6.95.

  • What is the current market cap of Genomed?

    The current market capitalization of Genomed is $9.2M.

  • What is Genomed’s current revenue?

    The trailing twelve month revenue for Genomed is $6.09M.

  • What is Genomed’s annual earnings per share (EPS)?

    Genomed’s EPS for 12 months was $0.37.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »